AlphaCore Capital LLC Has $354,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

AlphaCore Capital LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 28.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 606 shares of the healthcare conglomerate’s stock after acquiring an additional 135 shares during the period. AlphaCore Capital LLC’s holdings in UnitedHealth Group were worth $354,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the company. First County Bank CT boosted its stake in shares of UnitedHealth Group by 8.7% in the 3rd quarter. First County Bank CT now owns 2,660 shares of the healthcare conglomerate’s stock valued at $1,555,000 after purchasing an additional 213 shares in the last quarter. 49 Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 101.6% during the 3rd quarter. 49 Wealth Management LLC now owns 1,159 shares of the healthcare conglomerate’s stock valued at $678,000 after acquiring an additional 584 shares in the last quarter. Eagle Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 3.2% during the third quarter. Eagle Asset Management Inc. now owns 267,018 shares of the healthcare conglomerate’s stock valued at $164,433,000 after purchasing an additional 8,359 shares in the last quarter. HealthInvest Partners AB increased its stake in shares of UnitedHealth Group by 12.0% in the third quarter. HealthInvest Partners AB now owns 35,490 shares of the healthcare conglomerate’s stock valued at $20,750,000 after buying an additional 3,810 shares during the period. Finally, L & S Advisors Inc increased its holdings in UnitedHealth Group by 5.5% in the third quarter. L & S Advisors Inc now owns 6,425 shares of the healthcare conglomerate’s stock valued at $3,757,000 after purchasing an additional 333 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $597.56 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock’s fifty day moving average price is $582.70 and its 200-day moving average price is $551.92. The firm has a market cap of $549.92 billion, a P/E ratio of 38.93, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.